Oruka Therapeutics, Inc. Quarterly Revenues in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Oruka Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q1 2015 to Q1 2024.
  • Oruka Therapeutics, Inc. Revenues for the quarter ending March 31, 2024 was $0.000.
  • Oruka Therapeutics, Inc. annual Revenues for 2023 was $0.000.
  • Oruka Therapeutics, Inc. annual Revenues for 2022 was $0.000.
  • Oruka Therapeutics, Inc. annual Revenues for 2021 was $0.000.
Revenues, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-04-24
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-02
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-11
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-06
Q1 2019 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q1 2018 $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-08
Q1 2017 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q1 2016 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-11
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.